Metastasis is an extremely complex process that is a major problem in the management of cancer. In the present study, we had evaluated the antimetastatic activity of Decalepis hamiltonii using B16F-10 melanoma-induced experimental lung metastasis in a C57BL/6 mice model. D hamiltonii treatment significantly (P < .01) inhibited lung tumor nodule formation and reduced the lung collagen hydroxyproline, hexosamine, and uronic acid levels. Similarly serum sialic acid and γ-glutamyl transpeptidase levels were also significantly inhibited after D hamiltonii treatment. The levels of proinflammatory cytokines such as tumor necrosis factor α, interleukin (IL)-1β, IL-6, granulocyte monocyte colony-stimulating factor, and IL-2 in the serum of these animals were significantly altered after D hamiltonii treatment. The serum NO level was also found to be significantly decreased after D hamiltonii treatment. This decreased NO level after D hamiltonii treatment was also accompanied by decreased inducible NO synthase and cyclooxygenase-2 expression. The study reveals that D hamiltonii treatment could alter proinflammatory cytokine production and could inhibit the activation and nuclear translocation of p65 and p50 subunits of nuclear factor κB in B16F-10 cells.
Introduction
Cancer is one of the leading cause of death in India and around the world. It is a disease in which one or more cells in the body lose their normal growth-controlling mechanism and continue to grow, causing death of the host. A combination of lifestyle, exposure to environmental carcinogens, and the overall balance between inherited resistance and sensitivity genes is likely to determine the susceptibility of an individual to cancer. The essential characteristics of cancer cells are the ability to invade surrounding tissues and metastasize to regional and remote areas. The major clinical challenge for cancer therapy remains the eradication of metastasis. Metastasis is not a passive process but involves strict upregulations and downregulations in the expression of specific genes. Tumor cells, after detaching from the primary tumor, enter the blood vessels or lymphatics, circulate in the body fluids, and form a new colony at a distant site. 1 Metastasis is an extremely complex process that remains a major problem in the management of cancer. 2 Tumor cells break away from the primary tumor site and degrade proteins that make up the surrounding extracellular matrix (ECM) that separates the tumor from neighboring tissues. Cancer cells degrade the protein, breach the ECM, and metastasize to form secondary tumors at distant organs. 3 Metastatic cancer cells are generally identical to the cells of the primary cancer: breast cancer that spreads to the lungs and forms a metastatic tumor is known as metastatic breast cancer, not lung cancer. 4 Metastatic cancer cells and cells of the primary cancer usually have some molecular features in common, such as the expression of certain proteins or the presence of specific chromosome changes. The competence of metastasized cells depends on the host's immune cells at the niche, blood circulation, and capillary beds; most of the cancer cells are trapped by these barriers, but a few cancer cells prevail over these barriers and metastasize. Sometimes metastasized cancer cells can be dormant at a distance niche for many years and could redevelop at a later stage. 5, 6 Moreover, there are many molecules involved during metastasis, including adhesion molecules, as well as proteases, cell mobility, ECM, growth factors, oncogenes, and signal transduction and transcription factors.
Despite advances in early cancer diagnosis and treatment such as surgery, chemotherapy, radiotherapy, and adjuvant therapies, around 90% of cancer deaths are caused by metastases that are resistant to conventional therapies. 7 Although there are several drugs that are used for cancer therapy, there are no drugs available at present that block any single step in the metastatic process.
Natural products and their derivatives contribute to more than 50% of all the drugs in clinical use in the world. Higher plants contribute not less than 25% of the total. Almost 60% of drugs approved for cancer treatment are of natural origin. 8 Many experimental studies and clinical trials have shown that many plants play an important role in blocking of lung metastasis from primary tumors. [9] [10] [11] [12] Decalepis hamiltonii belongs to the family Leguminosae which has been reported to have several pharamacological activities, including antiulcer, 13 anti-inflammatory, 14 antioxidant, 15 hepatoprotective, 16 and antimicrobial activities. 17 We had previously reported that D hamiltonii possesses chemoprotective effects against cyclophosphamide-induced toxicity. 18 It has been reported to possess a variety of phytochemical constituents, out of which some compounds (vanillin, lupeol, and pectic polysaccharides) have been shown to inhibit the steps involved in the metastatic cascade. [19] [20] [21] [22] [23] [24] [25] [26] [27] However, there are no reports that validate the protective effect of D hamiltonii in inhibiting pulmonary metastasis. The objective of the present study is to study the protective effect of D hamiltonii during pulmonary metastasis and the possible mechanism of action.
Materials and Methods

Preparation and Administration of Plant Extract
D hamiltonii plants and roots were collected from Coimbatore, Tamil Nadu, India. The voucher specimen (ASC008) was deposited in the Department of Botany, MES Kalladi College, Mannarkkad, Tamil Nadu, India. D hamiltonii roots were shade dried, powdered, and extracted (10g) with 70% methanol (100 mL) by stirring overnight. The supernatant was collected after centrifugation at 5000 rpm for 10 minutes. The solvent was removed by evaporation, and the yield of the extract was found to be 12 %. For in vivo studies, the extract was resuspended in 1% gum acacia and administered at a concentration of 20 mg/kg body weight. This nontoxic concentration was selected based on the toxicity studies that we reported earlier. 18 
Animals
Male C57BL/6 mice (20-25 g) were purchased from the National Institute of Nutrition (Hyderabad, India). The animals were maintained in ventilated cages, fed with normal mouse chow (Sai Feeds, Mumbai, India), and given water ad libitum. All the animal experiments were performed after obtaining permission from the Institutional Animal Ethics Committee, Karunya University.
Cell Lines
The B16F-10 melanoma cells were procured from the National Centre for Cell Sciences, Pune, India. The cells were maintained in Dulbecco's modified eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS) and 1% antibiotics (penicillin and streptomycin) Chemicals MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], hydroxyproline, and glucuronic acid lactone were procured from Sigma Chemicals (St Louis, MO). N-acetyl neuraminic acid and papain were purchased from Sisco Research Laboratory (Mumbai, India). DMEM was purchased from HiMedia (Mumbai, India). All other reagents were of analytical reagent grade.
ELISA Kits
Highly specific quantitative sandwich ELISA kits for mouse interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, granulocyte monocyte colony-stimulating factor (GM-CSF), and IL-2 were procured from Koma Biotech, Gangseo-gu, Seoul, Korea. The γ-glutamyl transpeptidase (GGT) kit was purchased from Merck, Mumbai, India. Inducible NO synthase (iNOS) and cyclooxygenase (COX)-2 kits were purchased from USCN Life science Inc, Houston, TX, and Bluegene Biotech, Shanghai, China. Transcription factor profiling kits for p50 and p65 were procured from Cayman (Ann Arbor, MI).
Determination of the Effect of D hamiltonii on the Inhibition of Tumor Cell Growth
B16F-10 melanoma cells (5000 cells/well) were plated in a 96-well flat-bottomed titer plate and incubated at 37°C in 5% CO 2 atmosphere. (The viability of the cells was assessed using trypan blue dye, and only 100% viable cells were used for plating. The cell count was carried out using hemocytometer counting.) After 24 hours, escalating concentrations of D hamiltonii (10-100 µg/mL) were added, and the incubation was continued for 48 hours under the same conditions. Cell viability was determined by the MTT assay.
Determination of the Effect of D hamiltonii on Solid Tumor Development
C57BL/6 mice were divided into 2 groups (n = 6 animals/ group). Group I and group II were injected (intramuscular) in the right hind limb with B16F-10 melanoma cells (1 × 10 6 cells/mouse). Group I served as tumor control, whereas group II was treated with D hamiltonii (20 mg/kg body weight; intraperitoneally) for 10 consecutive days starting from the same day of tumor implantation. The radii of the developing tumor were subsequently measured using vernier calipers at 5-day intervals for 1 month. Tumor volume was calculated using the equation V = (4/3)πr 
Determination of the Effect of D hamiltonii on Lung Tumor Nodule Formation
C57BL/6 mice (20-25 g) were divided into 2 groups (n = 14 animals/group). Metastasis was induced in all the animals by injecting them with B16F-10 melanoma cells (10 6 cells/animal) via the lateral tail vein. 11 Group I served as metastasis control, whereas group II was treated with D hamiltonii (20 mg/kg body weight; intraperitoneally) for 10 consecutive days starting from the same day of tumor implantation. From each group, 8 animals were sacrificed after 21 days of tumor induction; their lungs were excised, and the number of lung tumor colonies was counted. The lungs were used to estimate the lung collagen hydroxyproline content, lung uronic acid and hexosamine, and the expression levels of iNOS and COX-2. A portion of the lungs was subjected to histopathology analysis. Blood was collected by cardiac puncture, and the serum was separated and used for the estimation of sialic acid and GGT level.
Determination of the Effect of D hamiltonii on the Survival Rate of Metastatic-Tumor-Bearing Animals
Six animals from each group of the previous experiment were observed for their survival rate, and the percentage increase in life span (ILS) was calculated using the formula: Percentage ILS = [(T − C)/C] × 100, where T represents the number of survival days of the treated animals, and C represents the number of survival days of the control animals.
Determination of the Effect of D hamiltonii on Lung Collagen Hydroxyproline, Lung Uronic Acid Content, and Lung Hexosamine Content During Metastasis
Lung collagen hydroxyproline was estimated by the Bergman and Loxley method. 28 The lungs were homogenized, and protein was precipitated using trichloroacetic acid and hydrolyzed using 6N HCl. The hydrolysate was evaporated to dryness, and the residue was dissolved in water and used for the estimation of hydroxyproline by the chloramine-T method. A standard graph was plotted using hydroxyproline standard.
The uronic acid content present in the lungs was estimated by the Bitter and Mair method. 29 The lungs were digested with crude papain and hydrolyzed. 30 The hydrolysate was treated with sulfuric acid. The uronic acid level was estimated in the presence of carbazole reagent at 530 nm. A standard graph was plotted using glucuronic acid lactone.
The hexosamine concentration in the lung tissue was estimated using the Elson and Morgan method. 31 Lyophilized tissue samples were hydrolyzed with 2N HCl and the hydrolysate was evaporated to dryness. The residue was dissolved in water and treated with 2% acetyl acetone. The hexosamine concentration was estimated in the presence of Ehrlich's reagent. 32 A standard graph was plotted by using glucosamine standard.
Determination of the Effect of D hamiltonii on the Inhibition of Serum Sialic Acid and GGT Level During Metastasis
Protein-bound serum sialic acid levels were estimated using thiobarbituric acid assay. 33 The serum was hydrolyzed using 0.2N sulfuric acid. The hydrolysate was oxidized with periodic acid and incubated for 1 minute at 37°C. The oxidation was terminated using sodium arsenate followed by the addition of thiobarbituric acid (6%). Sialic acid was estimated at 549 nm with reference to 632 nm after adding dimethyl sulfoxide (DMSO). Sialic acid content was determined from the standard graph plotted using n-acetyl neuraminic acid.
Serum GGT level was estimated using the highly specific quantitative sandwich ELISA kits per the manufacturer's instructions (Merck, Mumbai, India).
Determination of the Effect of D hamiltonii on Lung iNOS and COX-2 Expression During Metastasis
The lung tissue homogenates were used for the measurement of iNOS and COX-2 levels according to the manufacturer's instructions (USCN Life Science Inc, Houston, TX). The values were expressed as nanogram per gram tissue (for iNOS and MPO, respectively).
Determination of the Effect of D hamiltonii on Serum TNF-α, IL-1β, IL-6, GM-CSF, IL-2, and Nitrite During Metastasis
Blood was collected from each animal by cardiac puncture immediately after it was killed on day 21. The serum was separated and used for the estimation of TNF-α, IL-1β, IL-6, GM-CSF, and IL-2 levels using ELISA kits according to the manufacturer's instructions. Serum nitrite was estimated according to the method of Green et al. 34 
Determination of the Effect of D hamiltonii on the Phagocytic Index During Metastasis
The phagocytic index was determined using the carbon clearance test. The experiment was done as explained above. After 48 hours of the last dose of the extract, all the animals were injected with 0.1 mL of Indian ink via the tail vein. Blood samples were withdrawn from the orbital vein at 0 and 15 minutes after injection. A 50-µL blood sample was mixed with 4 mL of 0.1% sodium carbonate solution, and the absorbance was measured at 660 nm. The phagocytic index K was calculated using the equation:
where OD 1 and OD 2 are the optical densities at times t 1 and t 2 , respectively. 33 
Preparation of Nuclear Extracts
Nuclear extracts were prepared by previously published methods that were slightly modified. 35 B16F-10 cells were grown in a 25 cm 2 flask. When the cells had become subconfluent, they were treated with D hamiltonii (10 µg/mL) and incubated for 2 hours at 37°C and 5% CO 2 . The cells were washed with phosphate-buffered saline twice and incubated with TNF-α (10 pg/mL) for 30 minutes at 37°C in 5% CO 2 . Cells were washed with phosphate-buffered saline, dislodged with a cell scraper, and collected by centrifugation at 5000 rpm. The cell pellet was resuspended in ice cold cell lysis buffer containing HEPES (10 mM), MgCl 2 (1.5 mM), KCl (10 mM), phenylmethyl sulfonyl fluoride (1 mM), dithiothreitol (1 mM), Nonidet P40 (0.5%), and EGTA (1mM); this was followed by centrifugation at 5000 rpm for 15 minutes (Eppendorf, Hamburg, Germany). The cell pellet was resuspended in double the volume of lysis buffer, and the cells were disrupted by repeated, single rapid strokes using a sterile syringe. The nuclear pellet was resuspended in extraction buffer (0.2 mL) containing HEPES (20 mM), glycerol (25%), MgCl 2 (1.5 mM), NaCl (420 mM), phenylmethylsulfonyl fluoride (PMSF) (0.1 mM), and dithiothreitol (1 mM) and incubated in ice for 30 minutes. The nuclear suspension was centrifuged at 10 000 rpm for 15 minutes at 4°C, and the supernatant was collected as nuclear extract and used for transcription factor profiling. A portion of the nuclear extract was used for the estimation of protein concentration by the Bradford method.
Transcription Factor Profiling
Transcription factor profiling was done using the Cayman transcription factor kit (Cayman, Ann Arbor, MI). The kit provided rapid, high-throughput detection of specific transcription factors-namely, subunits of nuclear factor κB (NF-κB) such as p65 and p50. Using an ELISA-based format, the transcription kit detected the DNA-bound transcription factors. Bound transcription factors in the DNA were detected by specific primary antibodies toward NF-κB p65 and NF-κB p50 subunits. A horseradish peroxidase-conjugated secondary antibody was then used to detect the primary antibody. The enzymatic product was then measured using an ELISA reader, and the percentage inhibition was calculated using the following formula: 100 − [(Optical density of D hamiltonii treated/Optical density of control) × 100].
Histopathological Studies
The lung tissue from the metastasis group was fixed in 10% formaldehyde, dehydrated, and embedded in paraffin wax. Sections (4 µm) were stained with eosin and hematoxylin. The images were captured at 10× magnification.
Statistical Analysis
Results were expressed as mean ± standard deviation. Statistical evaluation was performed using 1-way ANOVA followed by Dunnett's test using Graphpad Instat version 3.0 for Windows 95 (Graph Pad Software, San Diego, CA). P < .05 was considered statistically significant.
Results
Effect of D hamiltonii on Solid Tumor Development
The effect of D hamiltonii on solid tumor development is shown in Table 1 . There as a gradual and steady increase in the tumor volume, and on day 30, the volume reached 2.61 mm 3 in control animals, whereas treatment with D hamiltonii significantly reduced the tumor volume to 1.90 mm 3 .
Effect of D hamiltonii on the Inhibition of Tumor Cell Growth
D hamiltonii was found to be 100% cytotoxic to B16F-10 melanoma cells at a concentration of 100 µg/mL and was nontoxic at a concentration of 10 µg/mL ( Table 2) .
Effect of D hamiltonii on Lung Tumor Nodule Formation and Survival Rate of Metastatic-Tumor-Bearing Animals
There was a significant reduction in lung tumor nodule formation when the animals were administered D hamiltonii (42 ± 5.2) simultaneously with the tumor cells ( Table 3 ). The untreated control animals had a massive number of tumor nodules (250 ± 5.2) on their lungs. The metastatictumor-bearing mice survived up to 33 days. The extracttreated animals were still alive after the termination of the experiment (90 days; Table 3 ).
Effect of D hamiltonii on Lung Collagen Hydroxyproline, Uronic Acid, and Hexosamine Content During Metastasis
The effect of D hamiltonii on the lung collagen hydroxyproline content is shown in Table 4 . Tumor-bearing animals showed an increased level of lung collagen hydroxyproline (24.4 µg/mg protein), which was significantly reduced in the animals treated with D hamiltonii (7.6 µg/mg protein), indicating decreased metastatic lung fibrosis. The lung hydroxyproline content in normal animals is 0.98 µg/mg protein. The uronic acid content in normal animals is 35 µg/100 mg tissue. The tumor-bearing control animals showed elevated levels of uronic acid in their lung tissue (318 µg/100 mg tissue), which was significantly reduced in the D hamiltonii-treated animals (62.2 µg/100 mg tissue), indicating decreased lung fibrosis. The hexosamine content of normal animals is 0.5 mg/100 mg lyophilized tissue. The tumor-bearing control animals showed an increased level of lung hexosamine (5.2 mg/100 mg lyophilized tissue), and the D hamiltonii-treated animals showed a significantly reduced level (1.2 mg/100 mg lyophilized tissue), indicating a decreased tumor burden ( Table 4 ).
Effect of D hamiltonii on the Inhibition of Serum Sialic Acid and GGT Level During Metastasis
The effect of D hamiltonii on the serum sialic acid level of metastatic-tumor-bearing animals is shown in Table 5 . The serum sialic acid level was found to be increased (116.2 µg/ mL) in the tumor-bearing control animals compared with the normal group (26.2 µg/mL). D hamiltonii treated animals showed a significant reduction (39.4 µg/mL) in the serum sialic acid content. Similarly, the higher levels of GGT (110.4 nmol p-nitroaniline/mL) in tumor-bearing control animals were significantly reduced to 42.2 nmol p-nitroaniline/mL after treatment with D hamiltonii (Table 5 ). (10 6 ) were injected into the right-hind limb (subcutaneously). D hamiltonii was administered intraperitoneally for 10 consecutive days. Controls were treated with the vehicle-gum acacia. Tumor volume was measured using vernier calipers and was calculated as V = (4/3)πr Experimental design is as given in Table 3 . Animals were killed on the 21st day, and their lungs were excised. Values are expressed as mean ± SD. **Significant compared with untreated controls, P < .01.
Effect of D hamiltonii on the Serum Nitrite Level During Metastasis
The effect of D hamiltonii on the serum nitrite level is shown in Table 6 . The serum nitrite levels of control animals were highly elevated (40.2 µmol), whereas administration of D hamiltonii significantly reduced the elevated levels of serum nitrite to 28.4 µmol.
Effect of D hamiltonii on Lung iNOS and COX-2 Expression During Metastasis
The effect of D hamiltonii on lung iNOS and COX-2 expression is shown in Table 7 . The elevated level of iNOS in control animals (65.6 ng/g tissue) was significantly reduced to 40.2 ng/mL after treatment with D hamiltonii. Similarly D hamiltonii treatment could significantly reduce the expression of COX-2 from 74.6 ng/g tissue (control) to 39.4 ng/g tissue ( Table 7) .
Effect of D hamiltonii on Serum TNF-α, IL-1β, IL-6, GM-CSF, and IL-2 During Metastasis
Proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 in the serum of metastasis-induced animals showed a varying pattern during the period of study. In control animals, the TNF-α level was significantly elevated to 325 pg/mL on the 21st day after tumor challenge. Administration of D hamiltonii could significantly decrease the level of TNFα to 182.6 pg/mL. The normal level of IL-1β is 18 pg/mL. In metastasis-induced animals, it was increased to 58.2 pg/ mL on the 21st day after tumor challenge. Administration of D hamiltonii could significantly lower this level to 33.2 pg/ mL. Serum IL-6 level was found to be significantly increased to 480 pg/mL in control animals, but this was significantly reduced to 276 pg/mL on the 21st day after tumor challenge in animals treated with D hamiltonii. Serum GM-CSF level showed an elevation in control animals (40.6 pg/mL) from the normal value of 20.2 pg/mL. Administration of D hamiltonii was found to significantly lower the elevated level of GM-CSF to 31 pg/mL (Table 8 ).
We also evaluated the effect of D hamiltonii on the immunopotentiating cytokine, IL-2 (T-cell growth factor) during metastasis. The IL-2 levels in the D hamiltoniitreated animals on day 21 were found to be significantly enhanced (29.8 pg/mL) when compared with the control group (21.4 pg/mL). The IL-2 level in normal animals was found to be 24 pg/mL ( Table 8 ).
Effect of D hamiltonii on the Phagocytic Index During Metastasis
The effect of D hamiltonii on the phagocytic index is shown in Table 9 . The decreased phagocytic index (K) in control Experimental design is as given in Table 3 . The animals were killed on the 21st day. Blood was collected, and the serum was separated and used for the estimation of sialic acid and GGT. Values are mean ± SD. **Significant compared with untreated controls, P < .01. Experimental design is as given in Table 3 . The animals were sacrificed on the 21st day. Blood was collected, and the serum was separated and used for the estimation of nitrite. Values are mean ± SD. **Significant compared with untreated controls, P < .01. Experimental design is as given in Table 3 . Animals were killed on the 21st day, and their lungs were excised and used for studying iNOS and COX-2 expression. Values are expressed as mean ± SD. **Significant compared with untreated controls, P < .01. The experimental design is given in Table 3 . Blood was collected from the caudal vein, and serum was used for the estimation of cytokine levels. Values are mean ± SD. *P < .05, **P < .01.
animals was found to be increased to 71.42% after treatment with D hamiltonii.
Effect of D hamiltonii on the Translocation of Transcription Factors
The DNA-bound transcription factor was first detected by the primary antibody. A horseradish peroxidase-conjugated secondary antibody was then used to detect the primary antibody. The enzymatic product was then measured spectrophotometrically. D hamiltonii treatment significantly inhibited the translocation of NF-κB subunits p65 and p50 ( Table 10) .
Effect of D hamiltonii on Lung Histopathology
Lung histopathology of the control animals showed prominent tumor nodules around the terminal bronchiole. These tumor nodules were composed of polygonal tumor cells with prominent nucleoluses. A clear area of necrosis was observed. The alveolar passage could not be distinguished because of massive infiltration of neoplastic cells ( Figure 1A) .
The lungs of D hamiltonii-treated animals showed a significant reduction in tumor mass. The alveoli and pleura were tumor free, and the alveolar passage was lined with healthy columnar epithelial cells ( Figure 1B ).
Discussion
One of the most challenging tasks in cancer research is to acquire more insight into mechanisms involved in the metastatic process, in which detached cells from the primary tumor can establish secondary tumors in distant sites. 36 The process of cancer metastasis involves a cascade of genetic alterations, and expression of the metastatic phenotypes depends on a balance between regulatory elements The experimental design is given in Table 3 . After 48 hours of the last dose of the extract, all the animals were injected with 0.1 mL of Indian ink via the tail vein. Blood samples were withdrawn from the orbital vein at 0 and 15 minutes after injection and estimated for phagocytic activity.
Values are mean ± SD. **Significant compared with untreated controls, P < .01. Abbreviation: NF, nuclear factor. a B16F-10 cells were cultured in a 25 cm 2 culture flask, treated with D hamiltonii (10 µg/mL), and incubated for 2 hours at 37°C in 5% CO 2 . Cells were washed with phosphate-buffered saline and incubated with TNF-α (10 pg/mL) for 30 minutes at 37°C in 5% CO 2 . Nuclear extracts were prepared separately and subjected to transfactor assay. Values are mean ± SD. *P < .05, **P < .01 compared with untreated controls. that promote or inhibit the process at one or more of the sequential steps. 37 Because most cancer deaths result from the disseminated disease, understanding the regulation of tumor invasion and metastasis is a central theme in tumor cell biology. 38 Although several drugs are available for cancer therapy, there are no drugs that can satisfactorily inhibit the metastatic process. Medicinal plants and plant-derived drugs can play a prominent role in the treatment of cancer. However, most of these plants have not been scientifically evaluated for their therapeutic efficacy and safety. In the present study, we analyzed the effect of D hamiltonii on the inhibition of lung metastasis: when administered simultaneously, there was 83.2% inhibition of lung nodules as compared with the untreated control group. Tumor nodules are metastatic colonies of B16F-10 melanoma cells formed in the lungs and initiate lung fibrosis and collagen deposition. This inhibition of tumor nodules correlated with an increase in the life span of the metastatic-tumor-bearing animals.
The state of lung fibrosis was evaluated by estimating the lung collagen hydroxyproline content because collagen is deposited massively in the alveolus of lungs during lung fibrosis. 39 Deposition of collagen during lung fibrosis results in reduced pulmonary function. 40 One of the major components in collagen is hydroxyproline (15%-30%). 41 The treatment with D hamiltonii showed significant reduction in lung hydroxyproline content, indicating less incidence of lung fibrosis. The oxidation of the primary alcohol group of aldoses of sugar derivatives in the tumor cells results in uronic acid production and leads to the formation of glucuronic acid lactone, which is an esterified form of glucuronic acid. In the presence of glucuronic acid lactone, prolyl hydroxylase enzyme converts the prohydroxyproline to hydroxyproline. Glucuronic acid lactone also activates the fiber formation during lung fibrosis. Hexosamine is a significant sugar derivative present in the tumor cells. It plays an important role in the synthesis of sialic acid (N-acetyl neuraminic acid), which is a component of glycolipids present on the surface of the tumor cells. 42 The enhanced levels of these compounds in the control animals indicated that constructive work was going on in the tissue-that is, tumor growth. After treatment with D hamiltonii, the amount of uronic acid, hydroxyproline, and hexosamine reduced significantly, indicating reduced tumor growth. The serum sialic acid and GGT levels were found to be higher in the tumor-bearing control animals. Tumor cells secrete glycoproteins, and shedding of gangliosides has been reported during metastasis. Sialic acid is an acylated derivative of neuraminic acid, usually occurring as a terminal component of carbohydrate chains of glycoprotein and glycolipids. The amount of sialic acid present on the tumor cell surface correlates directly with their metastatic ability. 43 GGT, a marker for cellular proliferation, was found to be increased in the serum of control animals compared with normal animals. Treatment with D hamiltonii reduced the GGT level significantly, thereby indicating its inhibitory effect on metastasis.
iNOS is overly expressed in several tumors, 44 and any natural product that can inhibit the expression of iNOS is of practical value. NO, synthesized by iNOS, is a mediator involved in different processes, such as neurotransmission, and affects the vasculature. The role of NO in tumor biology is ambiguous. NO has been reported to induce vasodilation or, as second messenger of other growth factors, gives rise to enhanced permeability in tumor vasculature. In such cases, the blood flow in the tumor will be increased, which would provide a favorable condition for the tumor. 45 Cytokines have also been implicated as putative mediators of metastasis. They act as soluble mediators of immune responses, participating in the communication and regulation of inflammatory responses. 46, 47 TNF-α has been shown to regulate many critical processes of tumor promotion and progression. [48] [49] [50] [51] IL-6 is a growth factor for hematological malignancies and has been found to stimulate vascular endothelial growth factor thereby affecting angiogenesis and metastasis. [52] [53] [54] [55] [56] GM-CSF is a pleiotropic cytokine produced by a number of different cell types, including macrophages, T-cell granulocytes, fibroblasts, endothelial cells, and various carcinoma cells. GM-CSF takes part in angiogenesis events, including in the differentiation of angioblasts into endothelial cells, their migration, and proliferation. 57, 58 Inhibition of TNF-α, IL-6, and GM-CSF was observed after treatment with D hamiltonii, which shows that regulation of metastasis occurs by a mechanism that regulates the production of proinflammatory cytokines. IL-2 is of clinical value in natural immunity, which stimulates natural killer cells and cytotoxic T-lymphocyte production. 59 In the present investigation, we found that administration of D hamiltonii could significantly increase the IL-2 level, which may contribute to the stimulation of the immune system against tumor growth.
The phagocytic index was determined to assess the effect of drugs on the reticuloendothelial system. The increase in carbon clearance index reflects the enhancement of the phagocytic function of mononuclear macrophages and nonspecific immunity. The phagocytic cells in this system are the main components of the mononuclear phagocyte system. Cells of the reticuloendothelial system and mononuclear phagocyte system are known to be important in the clearance of particles from the bloodstream. When Indian ink with carbon particles is injected directly into the blood stream for circulation, the rate of clearance of carbon from the blood by macrophage is governed by an exponential balance. 60 In this experiment, the increment in phagocytic index as seen from the carbon clearance test after administration of D hamiltonii supports the view that it stimulates the immune system. NF-κB proteins have been implicated as playing a major role in the cellular transformation by either providing a role in the cellular transformation, by providing a continued positive cell growth stimulus such as that mediated by cytokines, or through inhibition of apoptotic pathways. 61 NF-κB overexpression is required for the development of tumor invasiveness in melanomas. 62 The prototypical NF-κB is a heterodimer composed of p50 and p65 subunits, which are the major components of active NF-κB. Subunit p65-containing complexes bind with high affinity to the consensus DNA sequences 5′-GGGPuNNPyPyCC-3′ (p65/p50) or 5′-GGGPuNPyPyCC-3′ (P65/c-Rel), leading to the activation of transcription. 63 Many other heterodimers such as c-Rel/p52, RelB/p50,c-Rel/p50 and homodimers such as p52/p52 and p50/p50 have been reported in different cell types, which may vary depending on the cell type and stimuli. 64 In the present study, we found that D hamiltonii could inhibit the activation and nuclear translocation of transcription factors such as NF-κB p65 and NF-κB p50.
D hamiltonii has phytochemical constituents such as saponins, α-amyrins, β-amyrins, and lupeols and volatile compounds such as 2-hydroxy-4-methoxybenzaldehyde, vanillin, 2-phenylethyl alcohol, and benzaldehyde. In addition, it also contains compounds such as 4-hydroxy isophthalic acid, 14-aminotetradecanoic acid, 4-(1-hydroxy-1-methylethyl)-1-methyl-1,2-cyclohexanediol, 2,4,8 trihydroxybicyclo octan-3-one, and ellagic acid. [19] [20] [21] [22] [23] [24] [25] [26] [27] D hamiltonii has been reported to contain pectic polysaccharides, which could alter the matrix metalloprotease and prostaglandin E(2) levels. 65 Vanillin has been reported to inhibit metastasis in human and mouse cancer cells by inhibiting PI3K and decreasing tumor-specific angiogenesis. 66, 67 Lupeol, one of the major components present in D hamiltonii, has been reported to suppress NF-κB activation and inhibit tumor invasion as well as nodal metastasis. 68 4-(2-Hydroxypropan-2-yl)-1-methylcyclohexane-1,2-diol, 2,4,8-trihydroxybicyclo octan-3-one and 14-aminotetradecanoic acid isolated from D hamiltonii have been shown to exhibit antioxidant potential and protect cells against xenobiotic-induced cytotoxicity. [69] [70] [71] In conclusion, the present study shows that D hamiltonii could inhibit metastasis by inhibiting NO production and iNOS and COX-2 expression. Also, the present study shows that D hamiltonii could also alter proinflammatory cytokine production and could inhibit the activation and nuclear translocation of p65 and p50 subunits of NF-κB. Therefore, D hamiltonii may be used as a therapeutic target to inhibit metastasis during tumor progression. Further investigations are under way to trace out the exact mechanisms involved in the antimetastatic property of D hamiltonii.
